Management of Hypercapneic Respiratory Failure

Initial Assessment and Stabilization

The British Thoracic Society recommends initiating non-invasive ventilation (NIV) immediately if pH <7.35 and respiratory rate >23 breaths/min persist after 60 minutes of optimal medical therapy in patients with hypercapneic respiratory failure and PaCO2 >55 mmHg (1)
Obtain arterial blood gas analysis immediately to confirm hypercapnia and assess pH status in patients with suspected hypercapneic respiratory failure (2)
Start controlled oxygen therapy targeting SpO2 88-92% using 24-28% Venturi mask or nasal cannulae at 1-2 L/min to avoid worsening hypercapnia in patients with hypercapneic respiratory failure (3)
Initiate optimal medical therapy, including bronchodilators, corticosteroids (if COPD exacerbation), and treatment of underlying cause, in patients with hypercapneic respiratory failure (1, 2)

Repeat ABG after 60 minutes of optimal medical therapy in patients with PaCO2 ≥6.5 kPa (49 mmHg) AND pH <7.35 AND RR >23 (1, 2)
Start NIV immediately (Grade A recommendation) if criteria persist after 60 minutes of optimal medical therapy in patients with PaCO2 ≥6.5 kPa (49 mmHg) AND pH <7.35 AND RR >23 (1, 2)
Consider NIV rather than automatically initiating in patients with PaCO2 6.0-6.5 kPa (45-49 mmHg) (Grade D recommendation) (1, 2)

Discuss and document management plan if NIV fails with senior staff before starting NIV in patients with hypercapneic respiratory failure (4, 5)
Determine appropriate location (ICU, HDU, or respiratory ward based on pH) for NIV initiation in patients with hypercapneic respiratory failure (4, 6)
Start with bi-level pressure support (typical initial settings for COPD: IPAP 12-20 cmH2O, EPAP 4-5 cmH2O) and add supplemental oxygen to maintain SpO2 88-92% in patients with hypercapneic respiratory failure (4, 5, 3)

Repeat ABG at 1-2 hours after NIV initiation in patients with hypercapneic respiratory failure (4, 5, 2)
Consider intubation if PaCO2 and pH worsen after 1-2 hours on optimal NIV settings in patients with hypercapneic respiratory failure (4, 5, 2)

Never abruptly discontinue oxygen therapy if hypercapnia is discovered, as this causes life-threatening rebound hypoxaemia—instead step down gradually to 24-28% Venturi or 1-2 L/min nasal cannulae (3)
Avoid excessive oxygen use (PaO2 >10.0 kPa increases risk of worsening respiratory acidosis) in patients with hypercapneic respiratory failure (3)
Do not delay NIV in patients meeting criteria, as the 2016 BTS/ICS guidelines provide Grade A evidence for the PaCO2 ≥6.5 kPa threshold (1)

The severity of acidosis determines appropriate monitoring level, with pH ≥7.30 managed on respiratory ward, pH <7.30 requiring HDU/ICU level care, and pH <7.25 strongly considering ICU setting (2, 4, 1)

The British Thoracic Society (BTS) recommends that NIV be started immediately in patients with a COPD exacerbation who have respiratory acidosis (pH < 7.35) and an arterial PaCO₂ > 6.5 kPa that persists despite optimal bronchodilator and steroid therapy, provided the patient is alert and can protect the airway. Grade A evidence【7】.
A full‑face mask is the preferred initial interface for delivering bi‑level pressure support ventilation in COPD patients requiring NIV【7】.

Patients with an arterial pH < 7.25 should be managed in a high‑dependency or intensive‑care setting because they respond less well to NIV and have higher risk of failure【8】【9】.
After NIV initiation, arterial blood gases should be repeated 1–2 hours later to assess response. If PaCO₂ and pH worsen within this window, immediate intubation is indicated【8】.
If there is no clinical or biochemical improvement by 4–6 hours, an alternative management plan—typically escalation to invasive ventilation—should be instituted【8】【9】.

Prior to starting NIV, clinicians must document an escalation plan, including criteria for intubation and discussion with senior staff regarding the patient’s candidacy for invasive ventilation if NIV fails【8】.